By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Peregrine Pharmaceuticals, Inc. 

14272 Franklin Avenue, Suite 100

Tustin  California  92780  U.S.A.
Phone: 714-508-6000 Fax: 714-838-5817


SEARCH JOBS




Collaborations

AVANIR Pharmaceuticals 





Company News
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014 11:11:04 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014 8:17:00 AM
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014 3:28:26 PM
Phase II Clinical Data Presented At SITC Annual Meeting Support Immunotherapeutic Mechanism Of Action Of Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab In Liver Cancer 11/10/2014 10:53:32 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Data To Be Presented At The SITC Annual Meeting Support Synergy Of PS-Targeting And Anti-CTLA-4 Immunotherapies To Enhance Anti-Tumor Treatments In Melanoma 11/10/2014 10:47:00 AM
Promising Data Presented At The Chicago Multidisciplinary Symposium On Thoracic Oncology From An Investigator-Sponsored Trial Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab In Combination With Pemetrexed And Carboplatin In Front-Line Non-Small Cell Lung Cancer 10/30/2014 11:11:54 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Data To Be Published In The Journal Of Immunology Research Support Phosphatidylserine (PS) As A Potential Target In Ebola Infection 10/15/2014 11:21:18 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Data To Be Presented At CRI Immunotherapy Conference Show PS-Targeting Antibodies Enhance The Anti-Tumor Activity Of Immune Checkpoint Inhibitors By Decreasing Levels Of Myeloid Derived Suppressor Cells (MDSC) In The Tumor Microenvironment 10/6/2014 11:01:06 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/10/2014 12:00:46 PM
Peregrine Pharmaceuticals, Inc. (PPHM) Reports First Quarter Fiscal Year 2015 Financial Results And Recent Developments 9/10/2014 11:32:36 AM
12345678910...
//-->